Home > Boards > US OTC > Medical - Drugs > Tenax Therapeutics, Inc. (TENX)

TENX Levosimendan is what we refer to as

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
makingbiigdough Member Profile
 
Followed By 123
Posts 4,578
Boards Moderated 2
Alias Born 10/20/01
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 4:34:25 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:54:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2019 4:31:34 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/19/2019 4:32:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:34:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:34:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:33:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:33:39 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 4:33:58 PM
Tenax Therapeutics Enrolls First Patient for Phase 2 Pulmonary Hypertension Clinical Trial Business Wire - 3/11/2019 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 11:37:54 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2019 5:36:33 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/5/2019 2:08:30 PM
Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference Business Wire - 2/4/2019 8:30:00 AM
Tenax Therapeutics to Present at Biotech Showcase Investor Conference Business Wire - 1/4/2019 8:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/14/2018 3:45:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2018 4:07:59 PM
Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering Business Wire - 12/11/2018 4:00:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 12/10/2018 6:01:46 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 12/7/2018 5:12:47 PM
Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering Business Wire - 12/7/2018 1:02:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 12/6/2018 8:33:10 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 12/3/2018 5:28:07 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 11/20/2018 5:06:34 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/20/2018 4:33:39 PM
makingbiigdough   Sunday, 03/31/19 09:56:08 AM
Re: None
Post # of 7821 
TENX Levosimendan is what we refer to as a zip code changer!!!

Anybody sleeping on TENX right now and who does not have the patience in my opinion to buy and hold LONG doesn't need to be investing!

Levosimendan is a game-changer no-brainer if I ever saw one!! In the process of selling one of my houses all of the proceeds will be going into TENX!!! MBD

https://youtu.be/qPBq1rvnKLU

https://youtu.be/Q2BmzLD4Opo

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist